OBJECTIVE To describe obstetrician-gynecologists' practices and attitudes related to opioid use among pregnant and postpartum women. STUDY DESIGN A 2017 cross-sectional survey assessed U.S. obstetrician-gynecologists' (N = 462; response rate = 34%) practices (management) and attitudes (knowledge, preparedness, confidence, barriers, and resources needed) related to opioid use among pregnant and postpartum women. Modified Poisson regression determined adjusted prevalence ratios (aPR) for advising medication-assisted therapy (MAT) for pregnant women with opioid use disorder (OUD) by knowledge, confidence, and preparedness. RESULTS Of respondents, 33% always or usually advised MAT to pregnant women with OUD. Confidence in treating pregnant women who use opioids (aPR: 1.3, 95% CI: 1.0-1.8) and knowledge that substance use services were covered under the Affordable Care Act (aPR: 1.4, 95% CI: 1.1-1.8) were associated with advising MAT. CONCLUSION Evidence suggests that efforts are needed to enhance physician confidence to manage pregnant and postpartum patients who use opioids, which may increase optimal care of this patient population.

中文翻译：

---

妇产科医生在怀孕和产后使用阿片类药物的实践模式-美国，2017年。

目的描述孕妇和妇产科医生在孕妇和产后妇女中与使用阿片类药物有关的做法和态度。研究设计2017年的一项横断面调查评估了美国妇产科医师（N = 462;回复率= 34％）与孕妇使用阿片类药物有关的做法（管理）和态度（知识，准备，信心，障碍和所需资源）和产后妇女。修正的Poisson回归确定了调整后的患病率（aPR），以通过知识，信心和准备来为患有阿片类药物使用障碍（OUD）的孕妇提供药物辅助治疗（MAT）建议。结果在受访者中，有33％总是或通常建议OUD孕妇使用MAT。对使用阿片类药物的孕妇的治疗信心（aPR：1.3，95％CI：1.0-1。8）以及有关物质使用服务已涵盖在《平价医疗法案》（aPR：1.4，95％CI：1.1-1.8）中的知识与MAT咨询有关。结论有证据表明，需要努力增强医师对使用阿片类药物的孕妇和产后患者的信心，这可能会增加对该患者群体的最佳护理。